Uterine Fibroids Clinical Trials 2023

Uterine Fibroids Clinical Trials 2023

Uterine Fibroids research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in uterine fibroids clinical trials today.

Trials for Fibroid Patients

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to uterine fibroids

What are the top hospitals conducting uterine fibroids research?

Women who have struggled with uterine fibroids can find hope in the ongoing clinical trials conducted at various top hospitals. The Medical University of South carolina, located in charming Charleston, is currently engaged in two active trials focused on uterine fibroids. Though they may seem modest in number, these trials contribute to an ever-growing body of knowledge about this condition. The medical community's dedication to understanding and treating uterine fibroids is further evident at Chandler Hospital in Arizona, where researchers are actively conducting two trials as well. This bustling city has recently joined the efforts toward finding innovative solutions for women grappling with this health issue.

Meanwhile, Canoga Park Hospital in California boasts a history of five completed uterine fibroids trials since its first recorded study back in 2017. With two active trials underway presently, their commitment to advancing treatment options remains steadfast. In Hialeah, Florida, another hospital takes up the charge against uterine fibroids with four all-time conducted studies - starting from their initial trial also recorded back in 2017 - alongside two ongoing investigations aiming to identify novel approaches for managing this common gynecological concern.

Lastly but not leastly Lake Worth Hospital situated nearby serene Lake Worth region marks its entry into such research endeavors commencing theirs just last year2021but already showcasing potential by undertaking dual current experimental examinations targeting tackling issues surrounding such growths within uterus walls.

These hospitals' collective efforts underscore a shared mission: improving care and outcomes for women affected by uterine fibroids across different locations throughout the country. By participating in these clinical trials and contributing valuable data through research initiatives like these ones being carried out nationwide we pave path towards better understanding and hopefully more effective treatments that positively impact lives of countless individuals facing challenges related to this condition every day

Which are the best cities for uterine fibroids clinical trials?

Chicago, Atlanta, and Miami are among the top cities for uterine fibroids clinical trials. In Chicago, there are 12 ongoing trials investigating treatments like Myfembree Oral Product, Elagolix, and Green Tea Extract. Atlanta follows closely with 10 active trials focused on interventions such as Elagolix and Vilaprisan (BAY1002670). Meanwhile, Miami features 7 active trials exploring options like Elagolix and Dexamethasone. These cities offer individuals with uterine fibroids access to cutting-edge research aimed at finding effective treatment approaches and improving quality of life.

Which are the top treatments for uterine fibroids being explored in clinical trials?

Researchers are actively exploring a range of treatments for uterine fibroids in clinical trials. Among the top contenders is Myfembree Oral Product, which currently has one ongoing trial and holds the distinction of being the first treatment listed in 2022 specifically for uterine fibroids. Dexamethasone, another promising option, is also being investigated with one active trial and two all-time trials since its initial listing in 2014. Tranexamic Acid follows closely behind, with one ongoing trial and three all-time trials dating back to 2015. Lastly, Bupivacaine rounds out the list with one active trial and four all-time uterine fibroid trials since its first listing in 2019. With each study conducted, we inch closer to finding effective solutions for those affected by this condition.

What are the most recent clinical trials for uterine fibroids?

Exciting advancements in the field of uterine fibroid treatment are being made through recent clinical trials. One promising study involves the use of a relugolix combination tablet, which is currently in Phase 3. This medication shows potential for managing uterine fibroids effectively. Additionally, a Phase 4 trial focuses on QL Block with Bupivacaine as a possible solution for alleviating symptoms associated with uterine fibroids. Another Phase 3 trial explores the benefits of Green Tea Extract in addressing these common conditions. Furthermore, Myfembree Oral Product is under investigation in a Phase 4 study to determine its efficacy as a treatment option for uterine fibroids. These trials provide hope and highlight ongoing efforts to improve outcomes and quality of life for individuals affected by this condition.

What uterine fibroids clinical trials were recently completed?

Several recent clinical trials have investigated potential treatments for uterine fibroids, providing hope for patients grappling with this condition. In November 2020, Yale University completed a trial examining the effectiveness of Epigallocatechin gallate (EGCG). Additionally, Northwestern University conducted a trial involving ICG in June 2019. One notable study sponsored by Myovant Sciences GmbH focused on Relugolix and was completed in October 2018. These advancements underscore the ongoing efforts to find innovative therapies for uterine fibroids and improve the lives of affected individuals.